- Home
- GPN vs ICLR Comparison
GPN vs ICLR Comparison
Compare GPN & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GPN | ICLR |
|---|---|---|
| Founded | 1967 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9B | 15.1B |
| IPO Year | 2001 | 1998 |
Fundamental Metrics
Financial Performance| Metric | GPN | ICLR |
|---|---|---|
| Price | $75.71 | $187.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 13 |
| Target Price | $101.63 | ★ $202.31 |
| AVG Volume (30 Days) | ★ 3.2M | 907.8K |
| Earning Date | 02-12-2026 | 02-18-2026 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | ★ 34.30 | N/A |
| EPS | 7.12 | ★ 7.47 |
| Revenue | ★ $10,076,185,000.00 | $8,102,602,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.74 | $0.39 |
| P/E Ratio | ★ $10.67 | $24.99 |
| Revenue Growth | ★ 22.33 | N/A |
| 52 Week Low | $65.93 | $125.10 |
| 52 Week High | $114.17 | $211.00 |
Technical Indicators
Market Signals| Indicator | GPN | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 53.15 |
| Support Level | $71.56 | $173.42 |
| Resistance Level | $79.89 | $188.00 |
| Average True Range (ATR) | 2.39 | 7.66 |
| MACD | -0.46 | -0.78 |
| Stochastic Oscillator | 49.34 | 47.87 |
Price Performance
Historical ComparisonAbout GPN Global Payments Inc.
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares. The merger added issuer processing operations.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.